IBK Capital
VC Fund
Seoul, South Korea
IBK Capital is a VC fund in Seoul focused on Health Care and Biotechnology. IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).
- Total investments:
- 119
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries IBK Capital invests in
Stages IBK Capital invests in
Countries IBK Capital invests in
Round sizes
Round size
- Seed
- $148k–$4M
- Series A
- $1.5M–$11M
- Series B
- $3M–$17M
Investment Focus
Industry
- Health Care 18 (15%)
- Biotechnology 16 (13%)
- Information Technology 14 (12%)
- Medical 11 (9%)
- Artificial Intelligence 11 (9%)
Stage
- Series A 39 (33%)
- Seed 30 (25%)
- Series B 21 (18%)
- Venture - Series Unknown 13 (11%)
- Series C 8 (7%)
Country
- South Korea 106 (89%)
- United States 2 (2%)
- India 1 (1%)
- Singapore 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kitronyx is an engineering company that provides pressure distribution measurement and force touch products/solutions to individuals, companies, universities and government agencies.Based on seasoned expertise in pressure mapping and multi-touch technologies, Kitronyx has assisted many clients to employ professional pressure sensingtechniques in their applications and manufacturing processes.Kitronyx offers pressure mapping products and integrated solution including sensor, electronics, firmware, and software in the form of hardware development kit (HDK) or design service. | $1.5M / Series A / Sep 08, 2026 | ||
| BEYLESS is an embedded platform for autonomous driving. | $4M / Series B / Aug 25, 2026 | ||
| iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing. | $37.1M / Series A / Aug 19, 2026 | ||
| MID specializes in the development, testing, and production of space-related components. | $10.8M / Series A / Jul 29, 2026 | ||
| FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option. | $14M / Series B / Jun 16, 2026 | ||
| Automata creates AI-powered tools like AI agents and smart integrations that simplify how teams plan, communicate, and work. The company solves business problems by enabling AI to build, manage, and evolve software workflows while humans guide the AI to deliver real value.Automata provides industry-tailored AI solutions | $7.1M / Series A / Apr 24, 2026 | ||
| PEOPLE AND TECHNOLOGY provides DX-based AI solutions on INDOOR GEOLOCATION AND SMART SENSING through its INDOORPLUS+ IoT, Location Based System (LBS) and Real Time Location System (RTLS) platform in the fields of healthcare, manufacturing, defense, smart cities, and the public sector.More than 100 corporate customers in various business sectorssuch as healthcare, banking, manufacturing, retail, energy and public services have already chosen PEOPLE AND TECHNOLOGY to deploy industry grade solutions for employee safety, asset tracking & monitoring, security & access control, flow management and process efficiency. They have gained improvements in productivity and process efficiency while reducing their corporate risks and optimizing their procurement. Since its foundation in 2013, PEOPLE AND TECHNOLOGY has become a leading provider in South Korea and is expanding overseas. | $9.9M / Venture - Series Unknown / Apr 07, 2026 | ||
| As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia. | Series B / Feb 03, 2026 | ||
| Persona AI is a Korean artificial intelligence company that develops its own NLP-based conversational AI engine and AI contact center (AICC) solutions for businesses. It provides enterprise AI services such as chatbots, callbots, and automation platforms designed to improve customer communication and support operations. The company focuses onbuilding scalable AI infrastructure including edge AI and generative AI tools used across industries like healthcare, finance, and customer service. | $8.3M / Venture - Series Unknown / Feb 02, 2026 | ||
| Open Asset enables financial institutions to rapidly and effectively implement blockchain technology and exchange token assets. | Feb 02, 2026 | ||
| See all 119 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does IBK Capital invest in?
IBK Capital invests primarily in Health Care, Biotechnology and Information Technology startups, most often at Series A and Seed stage. Most of the 119 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is IBK Capital's check size?
IBK Capital typically joins rounds of $148k–$4M at Seed, $1.5M–$11M at Series A and $3M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IBK Capital participates in.
When did IBK Capital last invest?
The most recent investment recorded for IBK Capital closed in Sep 2026. Shizune tracks 119 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
